ZA961514B - Novel compositions - Google Patents

Novel compositions

Info

Publication number
ZA961514B
ZA961514B ZA961514A ZA961514A ZA961514B ZA 961514 B ZA961514 B ZA 961514B ZA 961514 A ZA961514 A ZA 961514A ZA 961514 A ZA961514 A ZA 961514A ZA 961514 B ZA961514 B ZA 961514B
Authority
ZA
South Africa
Prior art keywords
novel compositions
compositions
novel
Prior art date
Application number
ZA961514A
Other languages
English (en)
Inventor
Diego Oldani
Franco Francese
Original Assignee
Smithkline Beecham Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11370720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA961514(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Spa filed Critical Smithkline Beecham Spa
Publication of ZA961514B publication Critical patent/ZA961514B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA961514A 1995-02-28 1996-02-26 Novel compositions ZA961514B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI950379A IT1274655B (it) 1995-02-28 1995-02-28 Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico

Publications (1)

Publication Number Publication Date
ZA961514B true ZA961514B (en) 1996-11-06

Family

ID=11370720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961514A ZA961514B (en) 1995-02-28 1996-02-26 Novel compositions

Country Status (8)

Country Link
EP (1) EP0812193B1 (it)
JP (1) JPH11501019A (it)
AU (1) AU4940396A (it)
DE (1) DE69624343T2 (it)
HK (1) HK1006224A1 (it)
IT (1) IT1274655B (it)
WO (1) WO1996026724A1 (it)
ZA (1) ZA961514B (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003219348A1 (en) * 2002-04-22 2003-11-03 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
US6913759B2 (en) * 2003-03-11 2005-07-05 Curatek Pharmaceuticals Holding, Inc. Gel composition and method for treatment of vaginal infections
DE102004037598A1 (de) * 2004-08-03 2006-02-23 Prontomed Gmbh Mundspüllösung
EP2068900B1 (en) 2006-07-20 2015-04-15 Izun Pharmaceuticals Corporation Film-delivering rinse
BR112012000410B8 (pt) * 2009-07-08 2020-12-08 Acraf uso de benzidamina ou dos sais de adição de ácido, e, composição farmacêutica
ES2794824T3 (es) * 2015-01-13 2020-11-19 Acraf Composición farmacéutica para el tratamiento de la micosis
WO2016126217A1 (en) * 2015-02-03 2016-08-11 Pharmacti̇ve Ilaç Sanayi̇ Ve Ti̇caret A. Ş. Stable pharmaceutical combination containing benzydamine
JP6879681B2 (ja) * 2016-06-30 2021-06-02 サンスター株式会社 ラミネートチューブ容器用の口腔用ペースト状組成物
JP6758955B2 (ja) * 2016-06-30 2020-09-23 サンスター株式会社 口腔用ペースト状組成物
KR102461699B1 (ko) * 2021-05-21 2022-11-03 현대약품 주식회사 벤지다민염산염을 포함하는 안정성이 개선된 가글액

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2607945B2 (ja) * 1989-01-12 1997-05-07 サンスター株式会社 歯周組織修復促進組成物
GB9224598D0 (en) * 1992-11-24 1993-01-13 Smithkline Beecham Plc Novel compositions

Also Published As

Publication number Publication date
ITMI950379A1 (it) 1996-08-28
WO1996026724A1 (en) 1996-09-06
EP0812193B1 (en) 2002-10-16
EP0812193A1 (en) 1997-12-17
IT1274655B (it) 1997-07-18
AU4940396A (en) 1996-09-18
DE69624343D1 (de) 2002-11-21
DE69624343T2 (de) 2003-07-31
HK1006224A1 (en) 1999-02-19
JPH11501019A (ja) 1999-01-26
ITMI950379A0 (it) 1995-02-28

Similar Documents

Publication Publication Date Title
EG20993A (en) Cleasing compositions
EG20989A (en) Cleasing compositions
GB9613043D0 (en) Improved compositions
GB9508691D0 (en) Stable compositions
HUP9802544A3 (en) Cable-sheathing composition
SG52651A1 (en) Composition
PL322571A1 (en) Deodoising composition
GB9518033D0 (en) Composition
GB9500577D0 (en) Compositions
GB9504996D0 (en) Compositions
HUP9600352A2 (en) Bitumenous composition
GB9516371D0 (en) Compositions
ZA961514B (en) Novel compositions
GB9515805D0 (en) Compositions
AP9801229A0 (en) Solid compositions
GB9508785D0 (en) Novel compositions
GB9508323D0 (en) Composition
GB9510719D0 (en) Novel compositions
GB9604856D0 (en) Compositions
HUP9601550A2 (en) Particulale compositions
EP0757075A3 (en) Polyaminotriazine composition
GB9517113D0 (en) Novel compositions
GB9519109D0 (en) Compositions
GB9511701D0 (en) Composition
GB9504812D0 (en) Novel compositions